Thromb Haemost 1995; 74(01): 234-239
DOI: 10.1055/s-0038-1642683
Colloquium
Disorders Causing Thrombocytopenia
Schattauer GmbH Stuttgart

Human Platelet Alloantigens: Recent Findings, New Perspectives

Peter J Newman
Blood Research Institute, The Blood Center of Southeastern Wisconsin, Milwaukee, WI 53201, USA
,
Nathalie Valentin
Blood Research Institute, The Blood Center of Southeastern Wisconsin, Milwaukee, WI 53201, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
09 July 2018 (online)

 
  • References

  • 1 Newman PJ, McFarl JG, Aster RH. Alloimmune thrombocytopenias. In Thrombosis and Hemorrhage. Loscalzo J, Schafer AI. (eds.) Blackwell Scientific Publications; Boston: 1994. pp 529-543
  • 2 Newman PJ, Gorski J, White GC, Gidwitz S, Cretney CJ, Aster RH. Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction. J Clin Invest 1988; 82: 739-743
  • 3 Santoso S, Kalb R, Walka M, Kiefel V, Mueller-Eckhardt C, Newman PJ. The human platelet alloantigens Bra and Brb are associated with a single amino acid polymorphism on glycoprotein la (integrin subunit a2). J Clin Invest 1993; 92: 2427-2432
  • 4 Kuijpers RW A M, Faber NM, Cuypers HT M, Ouwehand WH, von dem Borne AE G K. The NH2-terminal globular domain of human platelet glycoprotein Iba has a methionine145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens. J Clin Invest 1992; 89: 381-384
  • 5 Noris P, Simsek S, De Bruijne-Admiraal LG, Porcelijn L, Huiskes E, van der Vlist G, van Leeuwen EF, van der Schoot CE, von dem Borne AE G K. Neonatal alloimmune thrombocytopenia (NATP) caused by a new low-frequency platelet specific alloantigen, Maxa, located on GPIIb. Blood 1994; 84: 527a-527a (abstract)
  • 6 Lyman S, Aster RH, Visentin GP, Newman PJ. Polymorphism of human platelet membrane glycoprotein lib associated with the Baka/Bakb alloantigen system. Blood 1990; 75: 2343-2348
  • 7 Poncz M, Newman PJ. Analysis of rodent platelet glycoprotein lib: evidence for evolutionarily conserved domains and alternative proteolytic processing. Blood 1990; 75: 1282-1289
  • 8 Santoso S, Kiefel V, Masri R, Mueller-Eckhardt C. Frequency of platelet-specific antigens among Indonesians. Transfusion 1993; 33: 739-741
  • 9 Perichon B, Clemenceau S, Rom A, Elion J, Kaplan C, Krishna moorthy R. An additional Hpall polymorphism in exon 2 of the human platelet membrane glycoprotein Ilia gene. Hum Genet 1994; 93: 353-354
  • 10 Unkelbach K, Kalb R, Santoso S, Kiefel V, Mueller-Eckhardt C. New polymorphism on platelet glycoprotein Ilia gene recognized by endonuclease Msp I: Implications for typing by allele-specific restriction analysis. Transition 1994; 34: 592-595
  • 11 Newman PJ, Derbes RS, Aster RH. The human platelet alloantigens, P1A1 and P1A2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein Ilia, and are distinguishable by DNA typing. J Clin Invest 1989; 83: 1778-1781
  • 12 Goldberger A, Kolodziej M, Poncz M, Bennett JS, Newman PJ. Effect of single amino acid substitutions on the formation of the P1A and Bak alloantigenic epitopes. Blood 1991; 78: 681-687
  • 13 Wang R, Furihata K, McFarl JG, Friedman K, Aster RH, Newman PJ. An amino acid polymorphism within the RGD binding domain of platelet membrane glycoprotein Ilia is responsible for the formation of the Pena/Penb alloantigen system. J Clin Invest 1992; 90: 2038-2043
  • 14 Kuijpers RW A M, Simsek S, Faber NM, Goldschmeding R, van Wermerkerken RK V, von dem Borne AE G K. Single point mutation in human glycoprotein Ilia is associated with a new platelet-specific alloantigen (Mo) involved in neonatal alloimmune thrombocytopenia. Blood 1993; 81: 70-76
  • 15 Wang R, McFarl JG, Kekomaki R, Newman PJ. Amino acid 489 is a mutational "hot spot" on the 03 integrin chain. The CA/Tu human platelet alloantigen system. Blood 1993; 82: 3386-3391
  • 16 Santoso S, Kalb R, Kroll H, Walka M, Kiefel V, Mueller-Eckhardt C, Newman PJ. A point mutation leads to an unpaired cysteine residue and a molecular weight polymorphism of a functional platelet 03 integrin subunit: The Sra alloantigen system of GPIHa. J Biol Chem 1994; 269: 8439-8444
  • 17 von dem Borne AE, Decary F. Nomenclature of platelet-specific antigens. Hum Immunol 1990; 29: 1-2
  • 18 von dem Borne AE, Decary F. ICSH/ISBT working party on platelet serology. Nomenclature of platelet-specific antigens. Vox Sang 1990; 58: 176
  • 19 Loftus JC, O’Toole TE, Plow EF, Glass A, Frelinger AL, Ginsberg MH. A beta 3 integrin mutation abolishes ligand binding and alters divalent cation-dependent conformation. Science 1990; 249: 915-918
  • 20 Flug F, Espinola R, Liu LX, SinQuee C, DaRosso R, Nardi M, Karpatkin S. A 13-mer peptide straddling the leucine33/proline33 polymorphism in glycoprotein Ilia does not define the PLA1 epitope. Blood 1991; 77: 1964-1969
  • 21 Bowditch RD, Tani PH, Halloran CE, Frelinger AL, III McMillan R, Ginsberg MH. Localization of a P1A1 epitope to the amino terminal 66 residues of platelet glycoprotein Ilia. Blood 1992; 79: 559-562
  • 22 Barron-Casella EA, Kickler TS, Rogers O, Casella JF. Expression and purification of functional recombinant epitopes for the platelet antigens, P1A1 and P1A2. Blood 1994; 84: 1157-1163
  • 23 Calvete JJ, Henschen A, Gonzalez-Rodriguez J. Assignment of disulphide bonds in human platelet GPIIIa. A disulphide pattern for the beta-subunits of the integrin family. Biochem J 1991; 274: 63-71
  • 24 Cieutat A-M, Rosa J-P, Letourneur F, Poncz M, Rifat S. A comparative analysis of cDNA-derived sequences for rat and mouse 03 integrins (GPIIIa) with their human counterpart. Biochem Biophys Res Commun 1993; 193: 771-778
  • 25 Ransom DG, Hens MD, DeSimone DW. Integrin expression in early amphibian embryos: cDNA cloning and characterization of Xenopus 01, 02, 03, and 06 subunits. Dev Biol 1993; 160: 265-275
  • 26 Wilcox DA, Wautier JL, Pidard D, Newman PJ. A single amino acid substitution flanking the fourth calcium binding domain of allb prevents maturation of the cdlb03 integrin complex. J Biol Chem 1994; 269: 4450-4457